Metabolic and Endocrine Complications of Long-COVID-19:  A Review

dc.contributor.author	Bandara, T.
dc.contributor.author	Deshmukh, H.A.
dc.contributor.author	Abdalla, M.
dc.contributor.author	Sathyapalan, T.
dc.date.accessioned	2023-08-16T08:34:58Z
dc.date.available	2023-08-16T08:34:58Z
dc.date.issued	2023-05-17
dc.identifier.issn	0947-7349
dc.identifier.uri	http://ir.lib.ruh.ac.lk/xmlui/handle/iruor/14131
dc.description.abstract	Over the past two years, the outbreak of coronavirus disease of 2019 (COVID-19) caused by severe acute respiratory syn drome coronavirus 2 (SARS-CoV-2) has centralized the interest of the health care systems and the scientific world. The major ity of COVID-19-infected individuals recover fully. However, about 12–50% of patients experience various mid- and long term effects after recovering from the initial illness. These mid and long-term effects are collectively known as post-COVID-19 condition or 'long-COVID'. In the coming months, the long term consequences of COVID-19 on the metabolic and endo crine systems may expect to rise and pose a global healthcare challenge. This review article discusses the possible metabolic and endocrine complications of long-COVID and the relevant research findings	en_US
dc.language.iso	en	en_US
dc.publisher	Thieme	en_US
dc.subject	ong-COVID-19	en_US
dc.subject	chronic COVID	en_US
dc.subject	post COVID-19 syndrome	en_US
dc.subject	Metabolic	en_US
dc.subject	Endocrine	en_US
dc.subject	Effects of long-COVID	en_US
dc.title	Metabolic and Endocrine Complications of Long-COVID-19: A Review	en_US
dc.type	Article	en_US